119 related articles for article (PubMed ID: 10630428)
1. Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody: clinical tools or clues for research?
Griffiths AM; Zachos M
J Pediatr Gastroenterol Nutr; 2000 Jan; 30(1):1-2. PubMed ID: 10630428
[No Abstract] [Full Text] [Related]
2. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
Kim BG; Kim YS; Kim JS; Jung HC; Song IS
Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody.
Filik L; Biyikoglu I
World J Gastroenterol; 2008 Dec; 14(47):7271. PubMed ID: 19084948
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
[TBL] [Abstract][Full Text] [Related]
5. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
Desreumaux P; Bourreille A; Colombel JF
Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
[No Abstract] [Full Text] [Related]
6. Serological markers in inflammatory bowel diseases.
Reumaux D; Sendid B; Poulain D; Duthilleul P; Dewit O; Colombel JF
Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):19-35. PubMed ID: 12617880
[TBL] [Abstract][Full Text] [Related]
7. Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.
Papadakis KA; Targan SR
Curr Gastroenterol Rep; 1999 Dec; 1(6):482-5. PubMed ID: 10980990
[TBL] [Abstract][Full Text] [Related]
8. [Serological markers in inflammatory bowel disease: differences among populations and limitations of their application].
Barahona-Garrido J; Hernández-Calleros J; Sarti HM; Cabiedes J; Yamamoto-Furusho JK
Gastroenterol Hepatol; 2009 May; 32(5):380-1. PubMed ID: 19457592
[No Abstract] [Full Text] [Related]
9. Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an Academic Medical Center.
Gupta A; Derbes C; Sellin J
Inflamm Bowel Dis; 2005 Oct; 11(10):898-902. PubMed ID: 16189419
[TBL] [Abstract][Full Text] [Related]
10. [Serologic disease markers in inflammatory bowel disease].
Domènech Morral E
Med Clin (Barc); 2004 Feb; 122(4):138-9. PubMed ID: 14967096
[No Abstract] [Full Text] [Related]
11. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
[TBL] [Abstract][Full Text] [Related]
12. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL
World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029
[TBL] [Abstract][Full Text] [Related]
13. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.
Montanelli A; Mainardi E; Vagni A; Villanacci V; Zambelli C; Cestari R; Cengia P; Minelli L; Missale G
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):201-7. PubMed ID: 15990710
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J
Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669
[TBL] [Abstract][Full Text] [Related]
15. [Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies: new biological tools for diagnosis of inflammatory bowel disease].
Bourreille A; Doubremelle M; Colombel JF
Rev Med Interne; 2003 Mar; 24(3):147-50. PubMed ID: 12657435
[No Abstract] [Full Text] [Related]
16. Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease.
Granito A; Muratori L; Muratori P; Guidi M; Lenzi M; Bianchi FB; Volta U
Gut; 2006 Feb; 55(2):296. PubMed ID: 16407392
[No Abstract] [Full Text] [Related]
17. The utility of ANCA and ASCA in inflammatory bowel disease.
Targan SR
Inflamm Bowel Dis; 1999 Feb; 5(1):61-3; discussion 66-7. PubMed ID: 10028450
[No Abstract] [Full Text] [Related]
18. Serological markers of inflammatory bowel disease in children from the Western region of Saudi Arabia.
Saadah OI; Al-Mughales JA
Arab J Gastroenterol; 2013 Jun; 14(2):78-82. PubMed ID: 23820506
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic tools in inflammatory bowel diseases].
Bouhnik Y
Rev Prat; 2005 May; 55(9):977-83. PubMed ID: 16052968
[TBL] [Abstract][Full Text] [Related]
20. Serological diagnosis of inflammatory bowel disease.
Rutgeerts P; Vermeire S
Lancet; 2000 Dec 23-30; 356(9248):2117-8. PubMed ID: 11191535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
